Security Class Action Lawsuit against Par Pharmaceutical Companies, Inc.
A security class action lawsuit has been filed on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Par Pharmaceutical Companies, Inc. (NYSE: PRX) between April 29, 2004 and July 5, 2006, inclusive (the “Class Period”) alleges that defendants violated federal securities laws by issuing a series of materially false and misleading statements to the market throughout the Class Period, which statements had the effect of artificially inflating the market price of the Company’s securities.
No class has yet been certified in the above action. If you are a member of the proposed class, you may move the court no later than September 15, 2006 to serve as a lead plaintiff for the proposed class. To be a member of the proposed class you need not take any action at this time, and you may retain counsel of your choice.
Filed under Class Action, General Law
You may also like to read
- Generic Drug Manufacturers Medical Malpractice Lawsuit Dismissed
- Pharmaceutical company to go for $18K global settlement
- Class action Law Suit for Breach of Security
- Pharmaceutical giant Merck decided to pay lawsuit settlement agreement
- $150 Million Class Action Settlement by Drug Makers
- $150 Million Class Action Settlement by Three Drug Makers
- Six Phone Companies in A Class Action Lawsuit by Area Customers
- Two Class Action Lawsuits Against NSA's Data Gathering Program
- Kentucky Receives $600,000 in Pharmaceutical Settlement
- Five Drug Companies Will be Sued For Alleged Overcharging by South Carolina Attorney General
